Cleared Traditional

K203827 - REMI (FDA 510(k) Clearance)

Mar 2021
Decision
90d
Days
Class 2
Risk

K203827 is an FDA 510(k) clearance for the REMI. This device is classified as a Reduced- Montage Standard Electroencephalograph (Class II - Special Controls, product code OMC).

Submitted by Epitel, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 29, 2021, 90 days after receiving the submission on December 29, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A User-specified And/or Sponsor-specified Locations With A Reduced Array (i.e. Less Than < 16) Of Electrodes.

Submission Details

510(k) Number K203827 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 29, 2020
Decision Date March 29, 2021
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMC - Reduced- Montage Standard Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A User-specified And/or Sponsor-specified Locations With A Reduced Array (i.e. Less Than < 16) Of Electrodes